Areva - Reference Document 2016

121 / 386

11 RESEARCH AND DEVELOPMENT
PROGRAMS, PATENTS AND LICENSES
11.1. RESEARCH AND DEVELOPMENT
11.1.1. KEY FIGURES
Traditionally, research and development expenses are capitalized if they meet
the capitalization criteria established by IAS 38 and are recognized as research
and development expenses if they do not. In the income statement, research and
development expenses appear below gross margin and represent non-capitalizable
expenses incurred exclusively by the group; expenses relating to programs funded
wholly or partially by customers, together with projects carried out in partnerships
where AREVA has commercial rights of use of the results, are recognized in the
cost of sales. The total research and development expenditure consists of the
combination of amounts spent on research and development, whether capitalized
or expensed during the period.
In view of the adoption of IFRS 5 and of the classification of the group’s main
subsidiaries in operations “sold, discontinued or held for sale”, reported research
and development expenses amount to 13 million euros and were stable in relation
to the restated amount of 2015.
(in millions of euros) 2016 2015
Research and development recognized as expenses under gross margin, after RTC (1) 13 13
Of which expenses for mineral exploration and mining studies 0 0
Research and development recognized as expenses under gross margin, excluding expenses for
mineral exploration and mining studies, after RTC (1)
RTC (1) 1 2
Research and development recognized as expenses under gross margin, excluding expenses for
mineral exploration and mining studies, before RTC (1) 14 15
Capitalized research and development costs 0 0
TOTAL 14 15
Number of registered patents 0 0
(1) Research tax credit.
2016 AREVA REFERENCE DOCUMENT 121